Article
AI-designed AAV capsids deliver high-efficiency muscle gene transfer for low-dose therapy
2026-05-08
Abstract excerpt
<title>Abstract</title> <p>Muscular dystrophies are debilitating genetic disorders with no curative therapies. While AAV vectors offer promise, current capsids remain limited by pre-existing immunity, high-dose-induced toxicity, and manufacturing burden. We and others recently demonstrated that cross-species myotropism can be achieved by redirecting AAV tropism toward the conserved receptor αVβ6 integrin. Here, w...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bc00aad5-33bf-5e90-8444-8004c8b35dfd
- DOI
- 10.21203/rs.3.rs-9629847/v1
